For scientists and clinicians alike, one of the Holy Grails for successfully treating and curing Lyme disease is developing tests that identify the disease sooner, show when people are cured of infection, and can diagnose reinfection.
Now, researchers at Tufts University School of Medicine say they have identified just such a testing mechanism. It detects a type of antibody that infected individuals produce against a substance the Lyme bacteria acquires from the host in order to grow. The researchers believe tests to detect these autoantibodies – antibodies that mistakenly target and react with a person's own tissues or organs – could provide clinicians with a way to diagnose the disease sooner, know whether treatment with antibiotics is working, and identify patients who have been reinfected.
Authors of the study, published today by the Journal of Clinical Investigation, are Peter Gwynne, Luke Clendenen, and Linden Hu of the school’s Department of Molecular Biology and Microbiology, and colleagues at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH).
Click here to read the entire article.
Source: Tufts University
Latest from Pest Control Technology
- PCO Follows the Carpenter Bee Clues
- Bird Control Can Be Lucrative, But it’s Not for Every Company, PCOs Report
- Gerry Wegner on the New PCT Field Guide to Stinging and Biting Arthropods
- PCO Bookkeepers & M&A Specialists Recognize Pinnacle Performance Award Winners
- Ground Control
- Scientists, PMPs Collaborating to Map Termite Distribution in Southern U.S.
- Viking Pest Control Organizes a Charity Bike Build for Local Families
- Gaining Control of Structure-Infesting Carpenter Ants